← All trials
NCT04893733
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2020
- Primary completion
- Sep 30, 2021
- Completion date
- Dec 31, 2021
- First posted
- May 19, 2021
- Last posted
- May 19, 2021
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Caja Nacional de SaludLead sponsor
- Caja Nacional de SaludReponsible party - principal investigator
- Hospital Obrero No 2 - C.N.S.Overall official - principal investigator
- International Society of NephrologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.